he Department of Biotechnology (DBT) has invited fresh proposals from
biotech companies for providing support on a cost sharing basis targeted
at development of novel and high risk futuristic technologies mainly
for viability gap funding and enhancing existing R&D capacities of
start-ups and SMEs in key areas of national importance and public good.
Under this advanced technology scheme Biotechnology Industry Partnership Programme (BIPP), the DBT supports large, medium, small scale companies as well as start-up on cost sharing basis. It would push for high risk, discovery linked innovation and accelerated technology development. Varying models of grants, loans or grant plus loans will be made available under the scheme. It will be one of the most enabling mechanisms to promote R&D in biotech industry and public private partnership programmes.
It will also focus on the evaluation and validation of biotech products and indigenous discovery, innovation and technology to products with focus on the products of national relevance or public benefit. BIPP is an advanced technology initiative by the DBT for supporting innovative and challenging R&D in industry.
Under this advanced technology scheme Biotechnology Industry Partnership Programme (BIPP), the DBT supports large, medium, small scale companies as well as start-up on cost sharing basis. It would push for high risk, discovery linked innovation and accelerated technology development. Varying models of grants, loans or grant plus loans will be made available under the scheme. It will be one of the most enabling mechanisms to promote R&D in biotech industry and public private partnership programmes.
It will also focus on the evaluation and validation of biotech products and indigenous discovery, innovation and technology to products with focus on the products of national relevance or public benefit. BIPP is an advanced technology initiative by the DBT for supporting innovative and challenging R&D in industry.
No comments:
Post a Comment